FindTrial
Sign In

To study effect of Satva and Rasayana Therapy

Critical Evaluation of existence of difference in therapeutic response in relation to changes in quality of life in cancer patients belonging to different satva and taking rasayana therapy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/10/028495
Enrollment
60
Registered
2020-10-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Intervention1: Nil: Nil

Sponsors

Rasayu Cancer Clinic
Lead Sponsor
Rasayu Cancer Clinic
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient diagnosed with histologically confirmed breast Carcinoma 2.Patients willing to participate in the study and willing to fill study related questionnaires

Exclusion criteria

Exclusion criteria: 1 Patients receiving any conventional therapy for treatment of Anxiety or depression 2 Patients with cognitive dysfunction 3 Patients with brain metastasis 4.Patients taking analgesics

Design outcomes

Primary

MeasureTime frame
Correlation between treatment outcome-quality of life and satva will be assessedTimepoint: Pre and Post therapy at monthly interval Satwa score and Fact G score will be assesed by using measuring tools—

Secondary

MeasureTime frame
To assess anxiety and depressionTimepoint: Pre and post Rasayana therapy at monthly interval Anxity and depression levels will be assessed by using HADS scale—

Countries

India

Contacts

Public ContactDr Yogesh Bendale

Rasayu Cancer Clinic

dr.bendale@gmail.com02024537149

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026